A groundbreaking study led by researchers at the USC Mark and Mary Stevens Neuroimaging and Informatics Institute has unveiled critical nuances in how amyloid pathology correlates with cognitive impairment and genetic risk factors across diverse populations. By leveraging advanced neuroimaging datasets from over 17,000 participants, including a substantial subset of Hispanic individuals, the team shed light on population-specific differences in Alzheimer’s disease biology that challenge prevailing assumptions. Their findings, recently published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, underscore the importance of inclusive research approaches for unraveling Alzheimer’s heterogeneity and guiding precision therapeutics.
Amyloid-beta protein accumulation in the brain, manifesting as plaques, is a hallmark pathological feature of Alzheimer’s disease. Traditionally, the burden of amyloid deposition has been closely linked to clinical symptoms of cognitive decline and to the presence of the APOE ε4 allele—a potent genetic risk factor for late-onset Alzheimer’s. However, the USC-led study reveals that these relationships manifest differently in Hispanic populations compared to non-Hispanic whites. Despite having cognitive impairment or carrying APOE ε4, Hispanic participants generally showed lower amyloid levels, suggesting alternative or additional mechanisms may contribute to dementia risk and progression in this group.
Central to this study’s success was the innovative use of the Global Alzheimer’s Association Interactive Network (GAAIN), a powerful data-sharing platform developed at Stevens INI. GAAIN enables researchers worldwide to harmonize and analyze large-scale Alzheimer’s datasets, overcoming longstanding barriers posed by heterogeneity in imaging technology, tracers, and data acquisition methods. The platform facilitated the integration of amyloid PET imaging data standardized using the Centiloid scale—an analytical tool designed to normalize amyloid burden measurements across different scanners and imaging protocols—allowing for unprecedented cross-cohort comparisons.
The research consortium amalgamated data from five prominent sources, including the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease study, the Alzheimer’s Disease Neuroimaging Initiative, and the Health and Aging Brain Study–Health Disparities among others. This meta-analytic approach enabled comprehensive examination of amyloid burden across a racially and ethnically diverse sample, encompassing a wide clinical spectrum from normal cognition to dementia. The depth and breadth of this database allowed for refined statistical analyses that accounted for confounding factors such as age, sex, level of education, and cognitive performance.
Investigators utilized the Centiloid scale as a unifying metric to quantitatively assess amyloid load. This scale transforms heterogeneous imaging data into standardized units, facilitating direct comparisons across multi-site studies that previously lacked uniformity. By employing such quantitative rigor, the team demonstrated that while amyloid positivity correlated strongly with cognitive impairment overall, Hispanic individuals displayed a distinct profile characterized by comparatively lower amyloid deposition at equivalent levels of cognitive deficit, even when carrying the APOE ε4 allele.
Genetic analyses further illuminated the complexity of disease risk. Although APOE ε4 status increased amyloid positivity in both Hispanic and non-Hispanic white participants, the strength of this association was markedly attenuated in Hispanic cohorts. Specifically, non-Hispanic white carriers had over a fourfold increased likelihood of amyloid pathology, whereas this risk was approximately two and a half times in Hispanic carriers. These differential risks suggest that genetic and environmental contexts modulate Alzheimer’s pathophysiology in a population-specific manner.
Importantly, the study cautions against simplistic interpretations that lower amyloid levels imply lower dementia risk in Hispanic populations. In fact, epidemiological data shows that Hispanic adults experience a disproportionate burden of dementia. The researchers propose that the pathogenesis in these populations may be driven by a confluence of factors beyond amyloid accumulation, including vascular comorbidities, social determinants of health, and potentially other as-yet-unidentified biological processes. This underscores the need for multi-dimensional investigative frameworks.
As anti-amyloid therapies emerge as frontline interventions in Alzheimer’s management, understanding population-level variability in amyloid pathology is paramount. Treatments targeting amyloid may yield differential efficacy, and precision medicine approaches must account for the heterogeneity elucidated by this study. Tailoring interventions based on nuanced biomarker profiles and genetic backgrounds could enhance therapeutic outcomes and equity in clinical care.
The study authors emphasize the necessity for further research with larger, more detailed Hispanic cohorts. Granular data on Hispanic ancestry and longitudinal follow-up will be critical to decipher the dynamics of amyloid deposition and cognitive decline. Additionally, incorporating assessments of vascular health and other metabolic factors may clarify contributors to the divergent amyloid-cognition relationships observed.
Stevens INI director Arthur W. Toga highlights the transformative potential of open data platforms like GAAIN for accelerating Alzheimer’s research across historically underrepresented populations. By fostering collaboration and data integration, these resources enable scientists to capture the biological complexity of dementia and propel the development of innovative, inclusive treatment paradigms.
In summary, this extensive meta-analysis not only challenges conventional paradigms regarding amyloid pathology and genetic risk in Alzheimer’s disease but also advocates for a broader, more inclusive scientific lens. As the global population ages and diversifies, such insights will be essential to addressing the multifaceted challenges of dementia care and research.
Subject of Research: People
Article Title: Association of cognitive impairment and APOE ε4 with Centiloids in Hispanic and non-Hispanic White cohorts
News Publication Date: 11-Jun-2026
Web References: https://ini.usc.edu, https://gaain.org
References: Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, DOI: 10.1002/alz.71586
Image Credits: Stevens INI
Keywords: Alzheimer disease, Neuroscience, Genetics, Aging populations
